I have worked in this field 20+ years in various capacities . .

I know what I'm talking about.
Take U.S., as an example, please explain why small/mid-sized brand-name pharmas can prosper. But there are no small generic pharmas. I'm talking about generic drug maker, not distributors or those that acquire non-strategic assets from big pharmas.

所有跟帖: 

haha, what you said is exactly just why you do not know. You don -MICKEY222- 給 MICKEY222 發送悄悄話 MICKEY222 的博客首頁 (113 bytes) () 03/27/2013 postreply 07:11:24

Haha, look at the deal between Sirtris and GSK . . . -Fatcat999- 給 Fatcat999 發送悄悄話 (297 bytes) () 03/27/2013 postreply 07:27:30

請您先登陸,再發跟帖!